01671nam a2200385 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020002500112020002700137040002100164035002100185050002500206082001900231100002000250245015300270260004900423300001800472490005700490504006400547505013400611533015200745650004400897650004100941650002100982655002901003700001601032700001901048710001701067830005801084856012601142999001701268ebr10670813CaPaEBRm        u        cr cn|||||||||091020s2010    nyua    sb    001 0 eng d  z  2009044361  z9781608766932 (pbk.)  z9781617614576 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)83062785314aRC662.4b.K56 2010eb04a616.3/62072221 aKim, Sang Geon.10aAMPK-S6K1 signaling pathway as a target for treating hepatic insulin resistanceh[electronic resource] /cSang Geon Kim, Il Je Cho and Hee Yeon Kay.  aNew York :bNova Science Publishers,cc2010.  a59 p. :bill.1 aHepatology research and clinical developments series  aIncludes bibliographical references (p. [33]-49) and index.0 aIntroduction: Insulin signaling in hepatocytes -- Clinical and preclinical drugs for the treatment of hepatic insulin resistance.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aInsulin resistancexMolecular aspecsts. 0aLiverxDiseasesxMolecular aspecsts. 0aProtein kinases. 7aElectronic books.2local1 aCho, Il Je.1 aKay, Hee Yeon.2 aebrary, Inc. 0aHepatology research and clinical developments series.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10670813zAn electronic book accessible through the World Wide Web; click to view  c61831d61831